Citations

Citations to this article as recorded by  

• Quercus infectoria galls mitigates colitis in mice through alleviating mucosal barrier impairment and suppressing inflammatory factors
  Yan Ding, Jiao-Jiao Bai, Sabahat Ablimit, Muyassar Yasen, Arfidin Anwar, Kudelaidi Kuerban, Mubarak Iminjan, Guo-Qiang Zhang
  Journal of Ethnopharmacology.2025; 343: 119487.     CrossRef
• Main active components of Sishen Wan may modulate T cells-related proinflammatory cytokines via alleviating mitochondrial damage caused by oxidative stress in dextran sulphate sodium-induced ulcerative colitis
  Ke LI, Weiguang LV, Boning ZHANG, Shengnan HAN, Jing HAN, Yu ZHANG, Wei WANG, Weiyu ZANG, Anqi YANG, Hongjia WANG, Chenggang ZHANG
  Chinese Journal of Analytical Chemistry.2025; 53(9): 100562.     CrossRef

Crohn's disease (CD) is a chronic relapsing and remitting inflammatory disease of the gastrointestinal tract. CD is rare in Taiwan and other Asian countries, but its prevalence and incidence have been steadily increasing. A steering committee was established by the Taiwan Society of Inflammatory Bowel Disease to formulate statements on the diagnosis and management of CD taking into account currently available evidence and the expert opinion of the committee. Thorough clinical, endoscopic, and histological assessments are required for accurate diagnosis of CD. Computed tomography and magnetic resonance imaging are complementary to endoscopic evaluation for disease staging and detecting complications. The goals of CD management are to induce and maintain remission, reduce the risk of complications, and improve quality of life. Corticosteroids are the mainstay for inducing re-mission. Immunomodulating and biologic therapies should be used to maintain remission. Patients should be evaluated for hepatitis B virus and tuberculosis infection prior to treatment and receive regular surveillance for cancer. These consensus statements are based on current local evidence with consideration of factors, and could be serve as concise and practical guidelines for supporting clinicians in the management of patients with CD in Taiwan.

Citations

Citations to this article as recorded by  

• Factors affecting perception and acceptance of colonoscopy in patients with inflammatory bowel disease
  Chang-Hung Liao, Peng-Jen Chen, Yu-Lueng Shih, Wei-Kuo Chang, Tsai-Yuan Hsieh, Tien-Yu Huang
  Preventive Medicine Reports.2025; 49: 102951.     CrossRef
• Epidemiology and Steroid Dependency Reduction in Crohn’s Disease During the Biologics Era: A Nationwide Population-Based Study
  Nai-Yu Chen, Chiao-Hsiung Chuang, Yu-Ching Chang, Yea-Huei Kao Yang, Hua Hsu, Chieh-Min Chen, Ching-Lan Cheng
  Advances in Therapy.2025; 42(9): 4318.     CrossRef
• Crohn’s disease with initial manifestation of distal small intestine ulcers in a 6-year-old boy: A case report and literature review
  Shu-Wei Hu, Min-Yung Kuo
  Tungs' Medical Journal.2025; 19(2): 135.     CrossRef
• Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023
  Jia-Feng Wu, Hsu-Heng Yen, Horng-Yuan Wang, Ting-An Chang, Chung-Hsin Chang, Chen-Wang Chang, Te-Hsin Chao, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tzu-Chi Hsu, Tien-Yu Huang, Tsung-I Hung, Puo-Hsien Le, Chun-Che Lin, Chun-Chi Lin
  Intestinal Research.2024; 22(3): 250.     CrossRef
• Current State of CT Enterography in Diagnostics and Surgical Tactics in Crohn’s Disease (Literature Review)
  A. L. Aprosimov, D. A. Lezhnev, Yu. V. Kulezneva
  Radiology - Practice.2024; (6): 67.     CrossRef
• Suboptimal Outcomes and Retreatment Rate of Patients With Crohn's Disease After Forced Discontinuation of Biologics: A Nationwide Population‐Based Study
  Nai‐Yu Chen, Chiao‐Hsiung Chuang, Yu‐Ching Chang, Yea‐Huei Kao Yang, Peng‐Hsu Chen, Ching‐Lan Cheng
  Clinical Pharmacology & Therapeutics.2023; 114(4): 914.     CrossRef
• Health Maintenance and Preventative Care in Inflammatory Bowel Disease
  Simcha Weissman, Hannah K. Systrom, Ayrton Bangolo, Daniel Elias, Marcel Awasi, Tamer Zahdeh, Chukwuemeka E. Ogbu, Mishka Hoo Kim, Meenal Kalra, Kavya Khota, Ritu B. Kasarapu, Erasmus Mutabi, Moinulhaq Makrani, Sanskrita Nemalikanti, Jim Thomas, Joseph P.
  Journal of Clinical Gastroenterology.2023; 57(4): 325.     CrossRef
• Negative pressure wound management in perineal wound status post abdominoperineal resection and extralevator abdominoperineal excision: a meta-analysis and trial sequential analysis
  Cheng-Wei Fan, Po-Huang Chen, Hong-Jie Jhou, Yi-Chiao Cheng
  International Journal of Colorectal Disease.2023;[Epub]     CrossRef
• Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
  Eun Mi Song, Soo-Young Na, Sung Noh Hong, Siew Chien Ng, Tadakazu Hisamatsu, Byong Duk Ye
  Intestinal Research.2023; 21(3): 339.     CrossRef
• IBD barriers across the continents – East Asia
  Joyce Wing Yan Mak, Agnes Hiu Yan Ho, Siew Chien Ng
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Extra-Colonic Malignancy in Inflammatory Bowel Disease: a Paucity of Recommendations with Weak Evidence
  Simcha Weissman, Muhammad Aziz, Matthew R. Baniqued, Mohamed Ahmed, Sameh Elias, Joseph D. Feuerstein, James H. Tabibian
  Journal of Gastrointestinal Cancer.2022; 53(3): 669.     CrossRef
• Impact of Inflammatory Bowel Disease (IBD) and IBD Medications on Risk of Hyperlipidemia and in vitro Hepatic Lipogenic-Related Gene Expression: A Population-Based Cohort Study
  Ni Tien, Tien-Yuan Wu, Cheng-Li Lin, Chia-Jui Wu, Chung-Y Hsu, Yi-Jen Fang, Yun-Ping Lim
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Real‐world efficacy and safety of vedolizumab among patients with inflammatory bowel disease: A single tertiary medical center experience in Central Taiwan
  Yu‐Chiao Chiu, Chia‐Chang Chen, Chung‐Wang Ko, Szu‐Chia Liao, Hong‐Zen Yeh, Chung‐Hsin Chang
  Advances in Digestive Medicine.2021; 8(1): 40.     CrossRef
• Clinical features and treatment of inflammatory bowel disease in a low-incidence area
  Hsu-Heng Yen, Tsui-Chun Hsu, Mei-Wen Chen, Pei-Yuan Su, Yang-Yuan Chen
  Medicine.2021; 100(10): e25090.     CrossRef
• Quality assessment of clinical guidelines on probiotics therapy in children with IBD using the AGREE II instrument
  Haixin Cheng, Ziyin Ma, Boran Yu, Xiaohui Liu, Chao Tian, Xuli Zhong, Libo Zhao
  Journal of Clinical Pharmacy and Therapeutics.2021; 46(4): 1155.     CrossRef
• Clinicopathological and Molecular Features of Patients with Early and Late Recurrence after Curative Surgery for Colorectal Cancer
  Yuan-Tzu Lan, Shih-Ching Chang, Pei-Ching Lin, Chun-Chi Lin, Hung-Hsin Lin, Sheng-Chieh Huang, Chien-Hsing Lin, Wen-Yi Liang, Wei-Shone Chen, Jeng-Kai Jiang, Shung-Haur Yang, Jen-Kou Lin
  Cancers.2021; 13(8): 1883.     CrossRef
• Chinese consensus on diagnosis and treatment in inflammatory bowel disease (2018, Beijing)
  
  Journal of Digestive Diseases.2021; 22(6): 298.     CrossRef
• Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study
  Hsu-Heng Yen, Pei-Yuan Su, Siou-Ping Huang, Lisha Wu, Tsui-Chun Hsu, Ya-Huei Zeng, Yang-Yuan Chen, Wan-Long Chuang
  PLOS ONE.2021; 16(5): e0252286.     CrossRef
• Systematic evaluation of the diagnostic approach of inflammatory bowel disease guidelines
  Bing‐He Xiao, Xu‐Dong Ma, Jia‐Jun Lv, Ting Yang, Xin‐Jie Liu, Li‐Ya An, Yu‐Xing Qi, Ming‐Liang Lu, Yong‐Qing Duan, Da‐Li Sun
  International Journal of Clinical Practice.2021;[Epub]     CrossRef
• Clinical significance of granulomas in Crohn's disease: A systematic review and meta‐analysis
  Seung Wook Hong, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Joo Sung Kim
  Journal of Gastroenterology and Hepatology.2020; 35(3): 364.     CrossRef
• Diagnostic efficacy of double-balloon enteroscopy in patients with suspected isolated small bowel Crohn’s disease
  Zihan Huang, Xiang Liu, Fei Yang, Guoxin Wang, Nan Ge, Sheng Wang, Jintao Guo, Siyu Sun
  BMC Gastroenterology.2020;[Epub]     CrossRef
• Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study
  Jesus K. Yamamoto-Furusho, Othman Al Harbi, Alessandro Armuzzi, Webber Chan, Enrique Ponce de Leon, Jiaming Qian, Marina Shapina, Murat Toruner, Chia-Hung Tu, Byong Duk Ye, Morgane Guennec, Cecilia Sison, Dirk Demuth, Olga Fadeeva, Qasim M. Rana Khan
  Digestive and Liver Disease.2020; 52(8): 869.     CrossRef
• Strengthened monitoring and optimized management of Crohn’s disease patients
  Jing-Jing Wang, Yi-Hong Fan, Rong Huang
  World Chinese Journal of Digestology.2020; 28(15): 660.     CrossRef
• Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries
  Rupa Banerjee, Raja Affendi Raja Ali, Shu Chen Wei, Shashi Adsul
  Gut and Liver.2020; 14(6): 685.     CrossRef
• Innovative Animal Model of DSS-Induced Ulcerative Colitis in Pseudo Germ-Free Mice
  Sona Gancarcikova, Stanislav Lauko, Gabriela Hrckova, Zuzana Andrejcakova, Vanda Hajduckova, Marian Madar, Livia Kolesar Fecskeova, Dagmar Mudronova, Kristina Mravcova, Gabriela Strkolcova, Radomira Nemcova, Jana Kacirova, Andrea Staskova, Stefan Vilcek,
  Cells.2020; 9(12): 2571.     CrossRef
• Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates
  Hau-Jyun Su, Yu-Tse Chiu, Chuan-Tai Chiu, Yen-Chun Lin, Chen-Yu Wang, Jui-Ying Hsieh, Shu-Chen Wei
  Journal of the Formosan Medical Association.2019; 118(7): 1083.     CrossRef
• Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study
  Hsu-Heng Yen, Meng-Tzu Weng, Chien-Chih Tung, Yu-Ting Wang, Yuan Ting Chang, Chin-Hao Chang, Ming-Jium Shieh, Jau-Min Wong, Shu-Chen Wei
  Intestinal Research.2019; 17(1): 54.     CrossRef
• Response to Chamberlin and Borody
  Gary R. Lichtenstein, Edward V. Loftus, Kim L. Isaacs, Miguel D. Regueiro, Bruce E. Sands
  American Journal of Gastroenterology.2019; 114(1): 171.     CrossRef
• Immunogenicity of biologic therapies: causes and consequences
  Wolf-Henning Boehncke, Nicolo Costantino Brembilla
  Expert Review of Clinical Immunology.2018; 14(6): 513.     CrossRef
• Changing treatment paradigms for the management of inflammatory bowel disease
  Jong Pil Im, Byong Duk Ye, You Sun Kim, Joo Sung Kim
  The Korean Journal of Internal Medicine.2018; 33(1): 28.     CrossRef
• Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study
  Ya-Chih Tien, Hsu-Heng Yen, Ching-Fang Li, Mei-Ping Liu, Yin-Tzu Hsue, Ming-Hui Hung, Ying-Ming Chiu
  Arthritis Research & Therapy.2018;[Epub]     CrossRef
• Balloon-Assisted Enteroscopy and Capsule Endoscopy in Suspected Small Bowel Crohn’s Disease
  Hsu-Heng Yen, Chen-Wang Chang, Jen-Wei Chou, Shu-Chen Wei
  Clinical Endoscopy.2017; 50(5): 417.     CrossRef

Ulcerative colitis (UC) is an inflammatory bowel disease characterized by chronic mucosal inflammation of the colon, and the prevalence and incidence of UC have been steadily increasing in Taiwan. A steering committee was established by the Taiwan Society of Inflammatory Bowel Disease to formulate statements on the diagnosis and management of UC taking into account currently available evidence and the expert opinion of the committee. Accurate diagnosis of UC requires thorough clinical, endoscopic, and histological assessment and careful exclusion of differential diagnoses, particularly infectious colitis. The goals of UC therapy are to induce and maintain remission, reduce the risk of complications, and improve quality of life. As outlined in the recommended treatment algorithm, choice of treatment is dictated by severity, extent, and course of disease. Patients should be evaluated for hepatitis B virus and tuberculosis infection prior to immunosuppressive treatment, especially with steroids and biologic agents, and should be regularly monitored for reactivation of latent infection. These consensus statements are also based on current local evidence with consideration of factors, and could be serve as concise and practical guidelines for supporting clinicians in the management of UC in Taiwan.

Citations

Citations to this article as recorded by  

• Factors affecting perception and acceptance of colonoscopy in patients with inflammatory bowel disease
  Chang-Hung Liao, Peng-Jen Chen, Yu-Lueng Shih, Wei-Kuo Chang, Tsai-Yuan Hsieh, Tien-Yu Huang
  Preventive Medicine Reports.2025; 49: 102951.     CrossRef
• Clinical Characteristics, Management, and Outcomes of Colitis-Associated Colorectal Cancer and the Comparison With Sporadic Colorectal Cancer in Taiwan
  Hsin-Yun Wu, Meng-Tzu Weng, Jen-Wei Chou, Hsu-Heng Yen, Chun-Chi Lin, Feng-Fan Chiang, Chen-Shuan Chung, Wei-Chen Lin, Chen-Wang Chang, Puo-Hsien Le, Chia-Jung Kuo, Ching-Pin Lin, Wen-Hung Hsu, Chiao-Hsiung Chuang, Tzung-Jiun Tsai, I-Che Feng, Shu-Chen We
  Clinical and Translational Gastroenterology.2025; 16(2): e00798.     CrossRef
• Epidemiology and Steroid Dependency Reduction in Crohn’s Disease During the Biologics Era: A Nationwide Population-Based Study
  Nai-Yu Chen, Chiao-Hsiung Chuang, Yu-Ching Chang, Yea-Huei Kao Yang, Hua Hsu, Chieh-Min Chen, Ching-Lan Cheng
  Advances in Therapy.2025; 42(9): 4318.     CrossRef
• The role of vitamin D deficiency and modifiable risk factors in patients with Crohn’s disease
  Xiaoyue Feng, Qin Yin, Ying Kang, Kang Jiang, Mengqing Xu, Fangyu Wang
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Intestinal ultrasonographic finding in ulcerative colitis patient: a cross-sectional study
  Abd-Elmoaty A. Abd-Elmoaty, Abd-Elwahab F. Ali, Saad R. Abd-Elwahed, Mohamed F. Morsi
  Al-Azhar Assiut Medical Journal.2025; 23(3): 408.     CrossRef
• Moxifloxacin promotes two-photon microscopic imaging for discriminating different stages of DSS-induced colitis on mice
  Yingtong Chen, Xiaoyi Xu, Min Wang, Xiang Wang, Yan Wang, Yong Zhang, Jin Huang, Yuwen Tao, Wentao Fan, Lili Zhao, Li Liu, Zhining Fan
  Photodiagnosis and Photodynamic Therapy.2024; 48: 104220.     CrossRef
• High prevalence of vitamin D deficiency in Taiwanese patients with inflammatory bowel disease
  Chen-Ta Yang, Hsu-Heng Yen, Pei-Yuan Su, Yang-Yuan Chen, Siou-Ping Huang
  Scientific Reports.2024;[Epub]     CrossRef
• Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023
  Hsu-Heng Yen, Jia-Feng Wu, Horng-Yuan Wang, Ting-An Chang, Chung-Hsin Chang, Chen-Wang Chang, Te-Hsin Chao, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tzu-Chi Hsu, Tien-Yu Huang, Tsung-I Hung, Puo-Hsien Le, Chun-Che Lin, Chun-Chi Lin
  Intestinal Research.2024; 22(3): 213.     CrossRef
• Systemic Immune-Inflammation Index: Unveiling the Diagnostic Potential in Ulcerative Colitis through a Comprehensive Systematic Review and Meta-Analysis
  Anas Elgenidy, Omar Alomari, Tasbih Emad, Sara K. Kamal, Islam E. Al Ghanam, Aya Sherif, Mohammed Al-mahdi Al-kurdi, Abdallah A. Helal, Yusof Mohamed Omar, Mohamed Rafiek Ramadan
  Gastroenterology & Endoscopy.2024;[Epub]     CrossRef
• Real‐world experience of adalimumab therapy for patients with ulcerative colitis: A single tertiary medical center experience in Central Taiwan
  Hsu‐Heng Yen, Yu‐Chun Hsu, Chu‐Hsuan Kuo, Tsui‐Chun Hsu, Yang‐Yuan Chen
  Advances in Digestive Medicine.2023; 10(1): 28.     CrossRef
• Improvement of ulcerative colitis control by searching and restricting of inflammatory trigger factors in daily clinical practice
  Kun-Yu Tsai, Jeng-Fu You, Tzong-Yun Tsai, Yih Jong Chern, Yu-Jen Hsu, Shu-Huan Huang, Wen-Sy Tsai
  Intestinal Research.2023; 21(1): 100.     CrossRef
• Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study
  Wei-Chen Lin, Wei-Chen Tai, Chung-Hsin Chang, Chia-Hung Tu, I-Che Feng, Ming-Jium Shieh, Chen-Shuan Chung, Hsu-Heng Yen, Jen-Wei Chou, Jau-Min Wong, Yu-Hwa Liu, Tien-Yu Huang, Chiao-Hsiung Chuang, Tzung-Jiun Tsai, Feng-Fan Chiang, Chien-Yu Lu, Wen-Hung Hs
  Inflammatory Bowel Diseases.2023; 29(11): 1730.     CrossRef
• Health Maintenance and Preventative Care in Inflammatory Bowel Disease
  Simcha Weissman, Hannah K. Systrom, Ayrton Bangolo, Daniel Elias, Marcel Awasi, Tamer Zahdeh, Chukwuemeka E. Ogbu, Mishka Hoo Kim, Meenal Kalra, Kavya Khota, Ritu B. Kasarapu, Erasmus Mutabi, Moinulhaq Makrani, Sanskrita Nemalikanti, Jim Thomas, Joseph P.
  Journal of Clinical Gastroenterology.2023; 57(4): 325.     CrossRef
• Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
  Eun Mi Song, Soo-Young Na, Sung Noh Hong, Siew Chien Ng, Tadakazu Hisamatsu, Byong Duk Ye
  Intestinal Research.2023; 21(3): 339.     CrossRef
• Association between ulcerative colitis and Helicobacter pylori infection: A case-control study
  Iyad Ali, Qusay Abdo, Shayma'a M. Al-Hihi, Ansam Shawabkeh
  Heliyon.2022; 8(2): e08930.     CrossRef
• Impact of Inflammatory Bowel Disease (IBD) and IBD Medications on Risk of Hyperlipidemia and in vitro Hepatic Lipogenic-Related Gene Expression: A Population-Based Cohort Study
  Ni Tien, Tien-Yuan Wu, Cheng-Li Lin, Chia-Jui Wu, Chung-Y Hsu, Yi-Jen Fang, Yun-Ping Lim
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Discovery and Validation of Potential Serum Biomarkers with Pro-Inflammatory and DNA Damage Activities in Ulcerative Colitis: A Comprehensive Untargeted Metabolomic Study
  Mingxiao Li, Rui Zhang, Mingjie Xin, Yi Xu, Shijia Liu, Boyang Yu, Boli Zhang, Jihua Liu
  Metabolites.2022; 12(10): 997.     CrossRef
• Chemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease
  Shun-Wen Hsiao, Hsu-Heng Yen, Yang-Yuan Chen
  Gut and Liver.2022; 16(6): 840.     CrossRef
• Serum homocysteine level was elevated in ulcerative colitis and can be applied as diagnostic biomarker
  Xiaoping Zhang, Shanshan Wang, Hongmin Wang, Junxia Wu, Qihua Tan
  Pteridines.2022; 33(1): 87.     CrossRef
• Real‐world efficacy and safety of vedolizumab among patients with inflammatory bowel disease: A single tertiary medical center experience in Central Taiwan
  Yu‐Chiao Chiu, Chia‐Chang Chen, Chung‐Wang Ko, Szu‐Chia Liao, Hong‐Zen Yeh, Chung‐Hsin Chang
  Advances in Digestive Medicine.2021; 8(1): 40.     CrossRef
• Clinical features and treatment of inflammatory bowel disease in a low-incidence area
  Hsu-Heng Yen, Tsui-Chun Hsu, Mei-Wen Chen, Pei-Yuan Su, Yang-Yuan Chen
  Medicine.2021; 100(10): e25090.     CrossRef
• Comparison of outcomes of cyclosporine A and infliximab for steroid‐refractory acute severe ulcerative colitis
  Eun Mi Song, Eun Hye Oh, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Kyun Yang, Byong Duk Ye
  Journal of Gastroenterology and Hepatology.2021; 36(9): 2463.     CrossRef
• Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study
  Hsu-Heng Yen, Pei-Yuan Su, Siou-Ping Huang, Lisha Wu, Tsui-Chun Hsu, Ya-Huei Zeng, Yang-Yuan Chen, Wan-Long Chuang
  PLOS ONE.2021; 16(5): e0252286.     CrossRef
• Systematic evaluation of the diagnostic approach of inflammatory bowel disease guidelines
  Bing‐He Xiao, Xu‐Dong Ma, Jia‐Jun Lv, Ting Yang, Xin‐Jie Liu, Li‐Ya An, Yu‐Xing Qi, Ming‐Liang Lu, Yong‐Qing Duan, Da‐Li Sun
  International Journal of Clinical Practice.2021;[Epub]     CrossRef
• Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease?
  Shaghayegh Baradaran Ghavami, Hamid Asadzadeh Aghdaei, Dario Sorrentino, Shabnam Shahrokh, Maryam Farmani, Fatemeh Ashrafian, Maria Pina Dore, Shahrbanoo Keshavarz Azizi Raftar, Seyed Mobin Khoramjoo, Mohammad Reza Zali
  International Journal of Molecular Sciences.2021; 22(15): 8274.     CrossRef
• Efficacy and safety of Etiasa for treatment of mild-to-moderate ulcerative colitis: A Meta-analysis
  Fang-Mei Ling, Fei-Nan Lu, Sheng-Nan Wang, Liang-Ru Zhu
  World Chinese Journal of Digestology.2021; 29(15): 880.     CrossRef
• Association between Ulcerative Colitis and Helicobacter pylori Infection: A Case-Control Study
  Iyad Ali, Qusay Abdo, Shayma’a M. Al-Hihi, Ansam Shawabkeh
  SSRN Electronic Journal .2021;[Epub]     CrossRef
• A case with cytomegalovirus colitis and toxic megacolon initially diagnosed as Crohn's disease
  Shan-Han Chang, Hsin-Yun Sun, Chia-Tung Shun, Shu-Chen Wei
  Journal of the Formosan Medical Association.2020; 119(9): 1442.     CrossRef
• Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study
  Jesus K. Yamamoto-Furusho, Othman Al Harbi, Alessandro Armuzzi, Webber Chan, Enrique Ponce de Leon, Jiaming Qian, Marina Shapina, Murat Toruner, Chia-Hung Tu, Byong Duk Ye, Morgane Guennec, Cecilia Sison, Dirk Demuth, Olga Fadeeva, Qasim M. Rana Khan
  Digestive and Liver Disease.2020; 52(8): 869.     CrossRef
• Predictive values of stool-based tests for mucosal healing among Taiwanese patients with ulcerative colitis: a retrospective cohort analysis
  Hsu-Heng Yen, Mei-Wen Chen, Yu-Yao Chang, Hsuan-Yuan Huang, Tsui-Chun Hsu, Yang-Yuan Chen
  PeerJ.2020; 8: e9537.     CrossRef
• Ulcerative colitis
  Taku Kobayashi, Britta Siegmund, Catherine Le Berre, Shu Chen Wei, Marc Ferrante, Bo Shen, Charles N. Bernstein, Silvio Danese, Laurent Peyrin-Biroulet, Toshifumi Hibi
  Nature Reviews Disease Primers.2020;[Epub]     CrossRef
• Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries
  Rupa Banerjee, Raja Affendi Raja Ali, Shu Chen Wei, Shashi Adsul
  Gut and Liver.2020; 14(6): 685.     CrossRef
• To assess the effective and safety of berberine hydrochloride in ulcerative colitis
  Yong Zhang, Jin Wang, Daorui Hou, Shuguang Yan, Sijie Dang
  Medicine.2020; 99(49): e23482.     CrossRef
• Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates
  Hau-Jyun Su, Yu-Tse Chiu, Chuan-Tai Chiu, Yen-Chun Lin, Chen-Yu Wang, Jui-Ying Hsieh, Shu-Chen Wei
  Journal of the Formosan Medical Association.2019; 118(7): 1083.     CrossRef
• Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study
  Hsu-Heng Yen, Meng-Tzu Weng, Chien-Chih Tung, Yu-Ting Wang, Yuan Ting Chang, Chin-Hao Chang, Ming-Jium Shieh, Jau-Min Wong, Shu-Chen Wei
  Intestinal Research.2019; 17(1): 54.     CrossRef
• Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study
  Soo-Kyung Park, Sang Hyun Park, Chang Soo Eun, Geom Seog Seo, Jong Pil Im, Tae Oh Kim, Dong-Il Park
  Intestinal Research.2019; 17(3): 349.     CrossRef
• Effectiveness of sigmoidoscopy for assessing ulcerative colitis disease activity and therapeutic response
  Wei-Chen Lin, Chen-Wang Chang, Ming-Jen Chen, Tzu-Chi Hsu, Horng-Yuan Wang
  Medicine.2019; 98(21): e15748.     CrossRef
• Ulcerative Colitis in Elderly People: An Emerging Issue
  Wei-Chen Lin, Ming-Jen Chen, Cheng-Hsin Chu, Tsang-En Wang, Horng-Yuan Wang, Chen-Wang Chang
  International Journal of Gerontology.2018;[Epub]     CrossRef
• Response to hepatitis B vaccination in patients with inflammatory bowel disease: a prospective observational study in Korea
  Ji Young Chang, Sung-Ae Jung, Chang Mo Moon, Seong-Eun Kim, Hye-Kyung Jung, Ki-Nam Shim
  Intestinal Research.2018; 16(4): 599.     CrossRef
• Efficacy and Safety of Hou Gu Mi Xi on Spleen Qi Deficiency in Patients with Nonorganic Gastrointestinal Disorders: Protocol for a Multicenter, Randomized, Placebo‐Controlled Trial
  Xiaofan Chen, Heyun Nie, Wenjun Liu, Xu Zhou, Jianhua Nie, Bin Xie, Dongping Chen, Yiping Jiang, Kunhe Zhang, Ying Fu, Deping Yang, Yan Xiong, Zhangyang Zhao, Xin Sun, Weifeng Zhu, Carmen Mannucci
  Evidence-Based Complementary and Alternative Medicine.2018;[Epub]     CrossRef
• Challenges in the diagnosis of ulcerative colitis with concomitant bacterial infections and chronic infectious colitis
  Wei-Chen Lin, Chen-Wang Chang, Ming-Jen Chen, Cheng-Hsin Chu, Shou-Chuan Shih, Tzu-Chi Hsu, Horng-Yang Wang, John Green
  PLOS ONE.2017; 12(12): e0189377.     CrossRef

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by a relapsing and remitting course. The direct and indirect costs of the treatment of UC are high, and the quality of life of patients is reduced, especially during exacerbation of the disease. The incidence and prevalence of UC in Korea are still lower than those of Western countries, but have been rapidly increasing during the past decades. Various medical and surgical therapies, including biologics, are currently used for the management of UC. However, many challenging issues exist, which sometimes lead to differences in practice between clinicians. Therefore, the IBD study group of the Korean Association for the Study of Intestinal Diseases established the first Korean guidelines for the management of UC in 2012. This is an update of the first guidelines. It was generally made by the adaptation of several foreign guidelines as was the first edition, and encompasses treatment of active colitis, maintenance of remission, and indication of surgery for UC. The specific recommendations are presented with the quality of evidence and classification of recommendations.

Citations

Citations to this article as recorded by  

• Comparison of Effects on 6-Thioguanine Nucleotides According to Mesalazine Formulation in Pediatric Patients with Ulcerative Colitis
  Hansol Kim, Yoon Zi Kim, Seon Young Kim, Yon Ho Choe, Mi Jin Kim
  Clinical Therapeutics.2025; 47(3): 196.     CrossRef
• Comparison of 1‐Year Clinical Course in Patients With Newly Diagnosed Inflammatory Bowel Disease Between Vietnam and Korea: A Multinational, Multicenter Retrospective Cohort Study
  Luan Minh Dang, Eun Soo Kim, Kyeong Ok Kim, Yoo Jin Lee, Hoang Huu Bui, Chuong Dinh Nguyen, Chi Thi Nguyen, Nam Hoai Nguyen, Hien Thi‐Thu Nguyen, Nga Thi Dinh, Lien Thi‐Phuong Nguyen, Khien Van Vu, Minh Cuong Duong
  JGH Open.2025;[Epub]     CrossRef
• Ten-Year Trend in 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients with Ulcerative Colitis: An Analysis of Korean Health Insurance Data
  Soo Jung Park, Sang Won Park, Jae Hee Cheon
  Digestive Diseases and Sciences.2025;[Epub]     CrossRef
• The impact of gut microbiome enterotypes on ulcerative colitis: identifying key bacterial species and revealing species co-occurrence networks using machine learning
  Xuangao Wu, Ting Zhang, TianShun Zhang, Sunmin Park
  Gut Microbes.2024;[Epub]     CrossRef
• Complementary Therapeutic Effect of Fecal Microbiota Transplantation in Ulcerative Colitis after the Response to Anti-Tumor Necrosis Factor Alpha Agent Was Lost: A Case Report
  Jongbeom Shin, Ga Hyeon Baek, Boram Cha, Soo-Hyun Park, Jung-Hwan Lee, Jun-Seob Kim, Kye Sook Kwon
  Biomedicines.2024; 12(4): 800.     CrossRef
• Anti‐inflammatory and anti‐hyperalgesic effects induced by an aqueous aged black garlic extract in rodent models of ulcerative colitis and colitis‐associated visceral pain
  Maria Loreta Libero, Elena Lucarini, Lucia Recinella, Clara Ciampi, Serena Veschi, Anna Piro, Annalisa Chiavaroli, Alessandra Acquaviva, Nilofar Nilofar, Giustino Orlando, Daniele Generali, Carla Ghelardini, Lorenzo di Cesare Mannelli, Antonio J. Montero‐
  Phytotherapy Research.2024; 38(8): 4177.     CrossRef
• Risks of Cancer Associated with Therapeutic Drugs for Inflammatory Bowel Disease
  Won Moon, Jae Jun Park
  The Korean Journal of Gastroenterology.2024; 83(6): 233.     CrossRef
• Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti-Tumor Necrosis Factors
  Sang Un Kim, Hyun Seok Lee
  The Korean Journal of Gastroenterology.2024; 84(2): 35.     CrossRef
• Inflammatory Bowel Disease: Pathophysiology, Treatment, and Disease Modeling
  Jiryeon Jang, Sehoon Jeong
  BioChip Journal.2023; 17(4): 403.     CrossRef
• Factors associated with the prescription of probiotics in patients with inflammatory bowel disease: a cross-sectional study
  Joo Kyung Kim, Jae Hee Cheon
  Journal of Yeungnam Medical Science.2023; 40(1): 37.     CrossRef
• Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
  Soo-Young Na, Chang Hwan Choi, Eun Mi Song, Ki Bae Bang, Sang Hyoung Park, Eun Soo Kim, Jae Jun Park, Bora Keum, Chang Kyun Lee, Bo-In Lee, Seung-Bum Ryoo, Seong-Joon Koh, Miyoung Choi, Joo Sung Kim
  Intestinal Research.2023; 21(1): 61.     CrossRef
• Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: a KASID multicenter cohort study
  Seung Hwan Shin, Kyunghwan Oh, Sung Noh Hong, Jungbok Lee, Shin Ju Oh, Eun Soo Kim, Soo-Young Na, Sang-Bum Kang, Seong-Joon Koh, Ki Bae Bang, Sung-Ae Jung, Sung Hoon Jung, Kyeong Ok Kim, Sang Hyoung Park, Suk-Kyun Yang, Chang Hwan Choi, Byong Duk Ye
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Low Serum Hepcidin Levels in Patients with Ulcerative Colitis – Implications for Treatment of Co-existent Iron-Deficiency Anemia
  Jagadish Ramasamy, Chinmai Jagadish, Abitha Sukumaran, Joe Varghese, Thenmozhi Mani, A. J. Joseph, Ebby George Simon, Molly Jacob
  Inflammation.2023; 46(6): 2209.     CrossRef
• Screening for Chemical Characterization and Pharmacological Properties of Different Extracts from Nepeta italica
  Alessandra Acquaviva, Simonetta Cristina Di Simone, Nilofar, Abdelhakim Bouyahya, Gokhan Zengin, Lucia Recinella, Sheila Leone, Luigi Brunetti, Abdullahi Ibrahim Uba, Osman Guler, Maruf Balos, Ugur Cakilcioğlu, Luigi Menghini, Claudio Ferrante, Giustino
  Plants.2023; 12(15): 2785.     CrossRef
• Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
  Eun Mi Song, Soo-Young Na, Sung Noh Hong, Siew Chien Ng, Tadakazu Hisamatsu, Byong Duk Ye
  Intestinal Research.2023; 21(3): 339.     CrossRef
• Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
  Yu Kyung Jun, Seong-Joon Koh, Dae Seong Myung, Sang Hyoung Park, Choon Jin Ooi, Ajit Sood, Jong Pil Im
  Intestinal Research.2023; 21(3): 353.     CrossRef
• Advancements in the Management of Moderate-to-Severe Ulcerative Colitis: A Revised 2023 Korean Treatment Guidelines
  Soo-Young Na
  The Korean Journal of Medicine.2023; 98(5): 223.     CrossRef
• Comparison of 1-Year Colectomy Risk Between the US and Korean Patients with Acute Severe Ulcerative Colitis: A Propensity Score Matching Analysis
  Eun Soo Kim, Kyeong Ok Kim, Byung Ik Jang, Eun Young Kim, Yoo Jin Lee, Hyun Seok Lee, Joon Seop Lee, Sung Kook Kim, Yun Jin Jung, Sang-Bum Kang, Manasi Agrawal, Ryan Ungaro, Jean-Frederic Colombel
  Digestive Diseases and Sciences.2022; 67(7): 2866.     CrossRef
• Cytomegalovirus in ulcerative colitis: an evidence-based approach to diagnosis and treatment
  Anuraag Jena, Shubhra Mishra, Anupam Kumar Singh, Aravind Sekar, Vishal Sharma
  Expert Review of Gastroenterology & Hepatology.2022; 16(2): 109.     CrossRef
• Efficacy of sigmoidoscopy for evaluating disease activity in patients with ulcerative colitis
  Su Bum Park, Seong-Jung Kim, Jun Lee, Yoo Jin Lee, Dong Hoon Baek, Geom Seog Seo, Eun Soo Kim, Sang-Wook Kim, So Yeong Kim
  BMC Gastroenterology.2022;[Epub]     CrossRef
• Identification of useful genes from multiple microarrays for ulcerative colitis diagnosis based on machine learning methods
  Lin Zhang, Rui Mao, Chung Tai Lau, Wai Chak Chung, Jacky C. P. Chan, Feng Liang, Chenchen Zhao, Xuan Zhang, Zhaoxiang Bian
  Scientific Reports.2022;[Epub]     CrossRef
• Oral beclomethasone dipropionate as an add-on therapy and response prediction in Korean patients with ulcerative colitis
  Kyuwon Kim, Hee Seung Hong, Kyunghwan Oh, Jae Yong Lee, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye, Sang Hyoung Park
  The Korean Journal of Internal Medicine.2022; 37(6): 1140.     CrossRef
• Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
  Soo-Kyung Park, Sang-Bum Kang, SangSoo Kim, Tae Oh Kim, Jae Myung Cha, Jong Pil Im, Chang Hwan Choi, Eun Soo Kim, Geom Seog Seo, Chang Soo Eun, Dong Soo Han, Dong Il Park
  The Korean Journal of Internal Medicine.2022; 37(5): 949.     CrossRef
• Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study
  Yehyun Park, Chang Hwan Choi, Hyun Soo Kim, Hee Seok Moon, Do Hyun Kim, Jin Ju Kim, Dennis Teng, Dong Il Park
  Intestinal Research.2022; 20(4): 452.     CrossRef
• Corticosteroid, a double-edged sword in inflammatory bowel disease management: possibility of reducing corticosteroid use through physician education
  Seulji Kim, Seong-Joon Koh
  Intestinal Research.2022; 20(4): 389.     CrossRef
• La escala control nutricional (CONUT): una herramienta prometedora para el cribado nutricional y como predictor de severidad en la colitis ulcerosa crónica idiopática
  J.L. de-León-Rendón, R.Y. López-Pérez, N.I. Gracida-Mancilla, B. Jiménez-Bobadilla, L. Alarcón-Bernés, S. Mendoza-Ramírez, J.A. Villanueva-Herrero
  Revista de Gastroenterología de México.2021; 86(2): 110.     CrossRef
• Advances in Management of Intestinal Behçet’s Disease: A Perspective From Gastroenterologists
  Jae Hee Cheon
  Journal of Rheumatic Diseases.2021; 28(1): 4.     CrossRef
• Tumor Necrosis Factor-Alpha Inhibitor-Associated Psoriatic Alopecia in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature
  Kyung Muk Jeong, Ji Yun Seo, Anna Kim, Yoo Sang Baek, Hae Jun Song, Jiehyun Jeon
  Annals of Dermatology.2021; 33(1): 82.     CrossRef
• The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis
  Yujin Jeong, Seong Ran Jeon, Hyun Gun Kim, Jung Rock Moon, Tae Hee Lee, Jae Young Jang, Jun-Hyung Cho, Jun Seok Park, Heesu Park, Ki-hun Lee, Jin-Oh Kim, Joon Seong Lee, Bong Min Ko, Suyeon Park
  Intestinal Research.2021; 19(1): 62.     CrossRef
• Comparative Study of Anti-Inflammatory Effect on DSS-Induced Ulcerative Colitis Between Novel Glycyrrhiza Variety and Official Compendia
  Sa-Haeng Kang, Young-Jae Song, Yong-Deok Jeon, Dong-Keun Kim, Jeong-Hyang Park, Ju-Ryoun Soh, Jong-Hyun Lee, Christopher Kitalong, Wonnam Kim, Hyo-Jin An, Jae-Ki Chang, Jeonghoon Lee, Jong-Sik Jin
  Applied Sciences.2021; 11(4): 1545.     CrossRef
• McN-A-343, a muscarinic agonist, reduces inflammation and oxidative stress in an experimental model of ulcerative colitis
  Diva de Aguiar Magalhães, Jalles Arruda Batista, Stefany Guimarães Sousa, Jayro dos Santos Ferreira, Lauanda da Rocha Rodrigues, Cynthia Maria Carvalho Pereira, José Victor do Nascimento Lima, Ieda Figueira de Albuquerque, Nayonara Lanara Sousa Dutra Beze
  Life Sciences.2021; 272: 119194.     CrossRef
• Comparison of Long-Term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis
  Yong Il Lee, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim, Jae Hee Cheon
  Gut and Liver.2021; 15(2): 232.     CrossRef
• The controlling nutritional status score: A promising tool for nutritional screening and predicting severity in ulcerative colitis patients
  J.L. de-León-Rendón, R.Y. López-Pérez, N.I. Gracida-Mancilla, B. Jiménez-Bobadilla, L. Alarcón-Bernés, S. Mendoza-Ramírez, J.A. Villanueva-Herrero
  Revista de Gastroenterología de México (English Edition).2021; 86(2): 110.     CrossRef
• Comparison of outcomes of cyclosporine A and infliximab for steroid‐refractory acute severe ulcerative colitis
  Eun Mi Song, Eun Hye Oh, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Kyun Yang, Byong Duk Ye
  Journal of Gastroenterology and Hepatology.2021; 36(9): 2463.     CrossRef
• Clinical Significance of Residual Nonrectal Inflammation in Ulcerative Colitis Patients in Clinical Remission
  Jongbeom Shin, Sung Min Kong, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Young-Ho Kim
  Gut and Liver.2021; 15(3): 401.     CrossRef
• The real-world outcomes of vedolizumab in patients with ulcerative colitis in Korea: a multicenter retrospective study
  Byong Duk Ye, Jae Hee Cheon, Ki Hwan Song, Joo Sung Kim, Young-Ho Kim, Hyuk Yoon, Kang-Moon Lee, Sang-Bum Kang, Byung Ik Jang, Jae Jun Park, Tae Oh Kim, Dae-Wook Lee, Chee Yoong Foo, Jeong Eun Shin, Dong Il Park
  Therapeutic Advances in Gastroenterology.2021;[Epub]     CrossRef
• Efficacy and safety of Etiasa for treatment of mild-to-moderate ulcerative colitis: A Meta-analysis
  Fang-Mei Ling, Fei-Nan Lu, Sheng-Nan Wang, Liang-Ru Zhu
  World Chinese Journal of Digestology.2021; 29(15): 880.     CrossRef
• Draft Genome Sequence of Paraclostridium bifermentans subsp. muricolitidis Strain PAGU 1678 T , Which Exacerbates Pathosis in a Mouse Model of Ulcerative Colitis
  Ryo Kutsuna, Tohru Miyoshi-Akiyama, Junko Tomida, Yoshiaki Kawamura, Steven R. Gill
  Microbiology Resource Announcements.2021;[Epub]     CrossRef
• Treatment of inflammatory bowel diseases: focusing on 5-aminosalicylates and immunomodulators
  You Sun Kim
  Journal of the Korean Medical Association.2021; 64(9): 596.     CrossRef
• Is fasting beneficial for hospitalized patients with inflammatory bowel diseases?
  Yong Eun Park, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim, Jung Nam Kim, Na Rae Lee, Jae Hee Cheon
  Intestinal Research.2020; 18(1): 85.     CrossRef
• Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study
  Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
  Digestive Diseases and Sciences.2020; 65(5): 1436.     CrossRef
• Fecal calprotectin is more accurate than fecal immunochemical test for predicting mucosal healing in quiescent ulcerative colitis: a prospective multicenter study
  Eun Soo Kim, Hyun Seok Lee, Sung Kook Kim, Eun Young Kim, Byung Ik Jang, Kyeong Ok Kim, Chang Heon Yang, Yoo Jin Lee
  Scandinavian Journal of Gastroenterology.2020; 55(2): 163.     CrossRef
• Multidirectional Pharma-Toxicological Study on Harpagophytum procumbens DC. ex Meisn.: An IBD-Focused Investigation
  Lucia Recinella, Annalisa Chiavaroli, Maurizio Ronci, Luigi Menghini, Luigi Brunetti, Sheila Leone, Bruno Tirillini, Paola Angelini, Stefano Covino, Roberto Venanzoni, Gokhan Zengin, Simonetta Di Simone, Maria Chiara Ciferri, Viviana di Giacomo, Amelia Ca
  Antioxidants.2020; 9(2): 168.     CrossRef
• Pregnancy outcomes in women with inflammatory bowel disease: a 10‐year nationwide population‐based cohort study
  Han H. Lee, Jung Min Bae, Bo‐In Lee, Kang‐Moon Lee, Jeong H. Wie, Jin S. Kim, Young‐Seok Cho, Sung‐Ae Jung, Sang W. Kim, Hwang Choi, Myung‐Gyu Choi
  Alimentary Pharmacology & Therapeutics.2020; 51(9): 861.     CrossRef
• Effect of Age on the Initiation of Biologic Agent Therapy in Patients With Inflammatory Bowel Disease: Korean Common Data Model Cohort Study
  Youn I Choi, Yoon Jae Kim, Jun-Won Chung, Kyoung Oh Kim, Hakki Kim, Rae Woong Park, Dong Kyun Park
  JMIR Medical Informatics.2020; 8(4): e15124.     CrossRef
• Mechanism-based Drug Therapy of Inflammatory Bowel Disease With Special Reference to Rheumatic Disease
  Jae Jun Park
  Journal of Rheumatic Diseases.2020; 27(3): 128.     CrossRef
• Sarcopenia Is a New Risk Factor of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease
  Min Kyu Kang, Kyeong Ok Kim, Min Cheol Kim, Jung Gil Park, Byung Ik Jang
  Digestive Diseases.2020; 38(6): 507.     CrossRef
• Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseases
  Minkyung Han, Yoon Suk Jung, Jae Hee Cheon, Sohee Park
  Journal of Gastroenterology and Hepatology.2019; 34(7): 1166.     CrossRef
• Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study
  Soo-Kyung Park, Sang Hyun Park, Chang Soo Eun, Geom Seog Seo, Jong Pil Im, Tae Oh Kim, Dong-Il Park
  Intestinal Research.2019; 17(3): 349.     CrossRef
• Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use
  Ho Suk Kang, Ja-Seol Koo, Kang Moon Lee, Dae-Bum Kim, Ji Min Lee, Yoon Jae Kim, Hyuk Yoon, Hyun Joo Jang
  World Journal of Gastroenterology.2019; 25(8): 989.     CrossRef
• A Real-World Analysis of Prescribing Patterns and Non-persistence of Anti-TNFα Therapy for Inflammatory Bowel Disease
  Eun Jin Jang, Jung Eun Ha, Seul Gi Im, Myeong Gyu Kim, Hyun Soon Sohn
  Clinical Drug Investigation.2019; 39(7): 625.     CrossRef
• Medication Use and Drug Expenditure in Inflammatory Bowel Disease: based on Korean National Health Insurance Claims Data (2010-2014)
  Jung Eun Ha, Eun Jin Jang, Seul Gi Im, Hyun Soon Sohn
  Korean Journal of Clinical Pharmacy.2019; 29(2): 79.     CrossRef
• Protective effects induced by alcoholic Phlomis fruticosa and Phlomis herba‐venti extracts in isolated rat colon: Focus on antioxidant, anti‐inflammatory, and antimicrobial activities in vitro
  Claudio Ferrante, Lucia Recinella, Maurizio Ronci, Giustino Orlando, Simonetta Di Simone, Luigi Brunetti, Annalisa Chiavaroli, Sheila Leone, Matteo Politi, Bruno Tirillini, Paola Angelini, Stefano Covino, Roberto Venanzoni, Sanda Vladimir‐Knežević, Luigi
  Phytotherapy Research.2019; 33(9): 2387.     CrossRef
• Current Evidence for the Management of Inflammatory Bowel Diseases Using Fecal Microbiota Transplantation
  Seong Ran Jeon, Jocelyn Chai, Christiana Kim, Christine H. Lee
  Current Infectious Disease Reports.2018;[Epub]     CrossRef
• Monitoring Disease Activity: How and When?
  Kang-Moon Lee
  The Korean Journal of Gastroenterology.2018; 71(2): 69.     CrossRef
• Novel treatments for inflammatory bowel disease
  Hyo Sun Lee, Soo-Kyung Park, Dong Il Park
  The Korean Journal of Internal Medicine.2018; 33(1): 20.     CrossRef
• How to Optimally Use Currently Available Drugs in a Therapeutic Algorithm?
  You Sun Kim
  The Korean Journal of Gastroenterology.2018; 71(2): 74.     CrossRef
• Endoscopic Transplantation of Mesenchymal Stem Cell Sheets in Experimental Colitis in Rats
  Sehyung Pak, Sung Wook Hwang, In Kyong Shim, Sang Mun Bae, Yeon- Mi Ryu, Han-Byul Kim, Eun-ju Do, Hye-Nam Son, Eun-ji Choi, Sun-ha Park, Sang-Yeob Kim, Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang, Nobuo Kanai, Masanori Maeda, Teruo Okano, Dong-Hoon Yang
  Scientific Reports.2018;[Epub]     CrossRef
• Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis?
  Seong Ran Jeon
  Intestinal Research.2018; 16(2): 163.     CrossRef
• Is Clostridium difficile infection a real threat in patients with ulcerative colitis? A prospective, multicenter study in Korea
  Dae Bum Kim, Kang-Moon Lee, Sang Hyoung Park, You Sun Kim, Eun Soo Kim, Jun Lee, Sung-Ae Jung, Geom Seog Seo, Ji Min Lee
  Intestinal Research.2018; 16(2): 267.     CrossRef
• Mesenchymal Stromal Cells in the Treatment of Perianal Fistulas in Crohn'S Disease
  Jesús Castro-Poceiro, Agnès Fernández-Clotet, Julián Panés
  Immunotherapy.2018; 10(14): 1203.     CrossRef
• Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia: A Randomized, Controlled Trial
  Hyuk Yoon, Dong Ho Lee, Yong-Hyun Lee, Ju-Cheol Jeong, Soo Teik Lee, Myung-Gyu Choi, Seong Woo Jeon, Ki-Nam Shim, Gwang Ho Baik, Jae Gyu Kim, Jeong Seop Moon, In-Kyung Sung, Sang Kil Lee, Poong-Lyul Rhee, Hwoon-Yong Jung, Bong Eun Lee, Hyun Soo Kim, Sang
  Gut and Liver.2018; 12(5): 516.     CrossRef
• Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
  Jihye Park, Jae Hee Cheon
  Intestinal Research.2017; 15(3): 263.     CrossRef
• Fatal infections in older patients with inflammatory bowel disease on anti-tumor necrosis factor therapy
  Way-Seah Lee, Najib Azmi, Ruey-Terng Ng, Sik-Yong Ong, Sasheela Sri La Ponnampalavanar, Sanjiv Mahadeva, Ida Hilmi
  Intestinal Research.2017; 15(4): 524.     CrossRef

Crohn's disease (CD) is a disease with chronic inflammation of unknown etiology involving any part of the gastrointestinal tract. The incidence and prevalence of CD are increasing recently in Asia. Half of the CD patients will have intestinal complications, such as strictures or fistulas, within 20 years after diagnosis. Twenty-five percentage of CD patients have had at least one small bowel stricture and 10% have had at least one colonic stricture and lead to significant complications. Most of these patients will require at least one surgery during their lifetime. Early diagnosis and evaluation with adequate managements for the patients can prevent disability and mortality of these patient. Here, we reviewed the current incidence of CD with stricture, the etiology of stricture, and how to diagnose and manage the stricture.

Citations

Citations to this article as recorded by  

• Inflammatory bowel disease and metabolic reprogramming: From pathological mechanisms to targeted interventions
  Zemin Tian, Yinde Huang, Ying Wang, Chenyu Zhao, Zhaokai Zhou, Hua Yang, Yuan Qiu
  Interdisciplinary Medicine.2026;[Epub]     CrossRef
• Colonic strictures in Crohn’s disease: a non-surgical survival
  Sarra Laabidi, Hamed Aboubecrine, Salma Souissi, Donia Gouiaa, Asma Labidi, Nadia Ben Mustapha, Anis Haddad, Amine Sebai, Meriem Serghini, Monia Fekih, Hanene Jaziri, Jalel Boubaker
  Future Science OA.2025;[Epub]     CrossRef
• Enteroscopic Balloon Dilation in Small Bowel Stricturing Crohn’s Disease: Long‐Term Outcomes and Risk Factors for Surgery in a Single‐Center Prospective Observational Study
  Sung Noh Hong, Ji Eun Kim, Eun Ran Kim, Dong Kyung Chang, Young‐Ho Kim
  United European Gastroenterology Journal.2025; 13(6): 958.     CrossRef
• MicroRNA Sequencing of Serum Exosomes Reveals miR205-5p as an Anti-Fibrogenic Factor Against Intestinal Fibrosis in Crohn’s Disease
  Ying Xie, Mieke van Daelen, Rebecca Park, Isabella Almaraz, Lindsey Fontenot, Florian Rieder, Wendy Ho, Berkeley Limketkai, David Q. Shih, Minjie Wei, Yiling Li, Hon Wai Koon
  International Journal of Molecular Sciences.2025; 26(8): 3778.     CrossRef
• The Role of Diet in Crohn’s Disease: From Etiology to Evidence-Based Management
  Fares Jamal, Mayar H Alatout, Muhammad Ali Khan, Syed B Pasha, Talha A Malik
  Cureus.2025;[Epub]     CrossRef
• Evaluating luminal and post-operative Crohn’s disease activity on magnetic resonance enterography: A review of radiological disease activity scores
  Richard W Lo, Gauraang Bhatnagar, Numan Kutaiba, Ashish R Srinivasan
  World Journal of Gastroenterology.2025;[Epub]     CrossRef
• Duodenal Crohn’s disease: Case report and systematic review
  Muniratu Amadu, Jonathan Soldera
  World Journal of Methodology.2024;[Epub]     CrossRef
• Infective Endocarditis After Endoscopic Stricture Dilation in Crohn's Disease
  André Gonçalves, Sandra Barbeiro, Carina Leal, Antonieta Santos, Helena Vasconcelos
  ACG Case Reports Journal.2024; 11(6): e01377.     CrossRef
• Association between nutritional status assessed by body mass index and Crohn's disease phenotype: A Nation-wide analysis
  Judwin Ndzo, Sudheer K. Vuyyuru, Thomas Trimble, Kaung Yan, Grazziela Figueredo, Gordon W. Moran
  Clinical Nutrition ESPEN.2024; 64: 290.     CrossRef
• Perioperative optimization of Crohn's disease
  Chun‐Chi Lin, Hung‐Hsin Lin, Hui‐Chuen Chen, Nai‐Chia Chen, I‐Lun Shih, Ji‐Shiang Hung, Te‐Cheng Yueh, Feng‐Fan Chiang, Ping‐Wei Lin, Yuan‐Yao Tsai, Shu‐Chen Wei
  Annals of Gastroenterological Surgery.2023; 7(1): 10.     CrossRef
• Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021
  Hiroshi Nakase, Motohiro Esaki, Fumihito Hirai, Taku Kobayashi, Katsuyoshi Matsuoka, Minoru Matsuura, Makoto Naganuma, Masayuki Saruta, Kiichiro Tsuchiya, Motoi Uchino, Kenji Watanabe, Tadakazu Hisamatsu, Akira Andoh, Shigeki Bamba, Motohiro Esaki, Mikihi
  Journal of Gastroenterology.2023; 58(4): 313.     CrossRef
• Ileocecal valve that cannot be intubated in Crohn’s disease: is this a sign of poor prognosis?
  Muhammed Bahaddin Durak, Cem Simsek, Bayram İnan, Ilhami Yuksel
  International Journal of Colorectal Disease.2023;[Epub]     CrossRef
• Effects of Mimosa caesalpiniifolia pre-formulation on the intestinal barrier during sodium dextran sulfate-induced colitis in Wistar rats
  Aline Garnevi-Fávero , Karina Nascimento-da Silva , Willian Rodrigues-Ribeiro , Caroline Marcantonio-Ferreira , Patrícia Sartorelli, Leonardo Cardili, Rita De Cássia-Sinigaglia , Joice Naiara Bertaglia-Pereira, Marcelo Aparecido-da Silva , Wagner Vilega
  Biomédica.2023; 43(2): 282.     CrossRef
• Small Bowel Imaging from Stepchild of Roentgenology to MR Enterography: Part I: Guidance in Performing and Observing Normal and Abnormal Imaging Findings
  Antonio Pierro, Laura Maria Minordi, Luigi Larosa, Giulia Guerri, Alessandro Grimaldi, Fabio Quinto, Fabio Rotondi, Annalisa Marcellino, Teresa Bevere, Raffaella Basilico, Roberto Iezzi, Savino Cilla
  Life.2023; 13(8): 1691.     CrossRef
• Small Bowel Imaging from Stepchild of Roentgenology to MR Enterography, Part II: The Reliable Disclosure of Crohn’s Disease and Non-Inflammatory Small Bowel Disorder Plot through MRI Findings
  Antonio Pierro, Laura Maria Minordi, Luigi Larosa, Carla Cipri, Giulia Guerri, Fabio Quinto, Fabio Rotondi, Annalisa Marcellino, Raffaella Basilico, Roberto Iezzi, Savino Cilla
  Life.2023; 13(9): 1836.     CrossRef
• Use of oral diet and nutrition support in management of stricturing and fistulizing Crohn's disease
  Kush Fansiwala, Neha D. Shah, Kelly A. McNulty, Mary R. Kwaan, Berkeley N. Limketkai
  Nutrition in Clinical Practice.2023; 38(6): 1282.     CrossRef
• Congenital Partial Colonic Agenesis in Dogs and Cats: Clinical, Biological, Diagnostic Imaging, Endoscopic and Histopathologic Characterization, a Retrospective Study
  Paul Remmel, Lucile Gros, Jérémy Mortier, Valérie Freiche
  Veterinary Sciences.2023; 10(9): 577.     CrossRef
• Infective endocarditis as possible complication of endoscopic stricture dilation in Crohn's disease
  A. Gonçalves, M. Silva, S. Barbeiro, H. Vasconcelos
  Endoscopy.2023; 55(S 02): S87.     CrossRef
• Revisiting fibrosis in inflammatory bowel disease: the gut thickens
  Silvia D’Alessio, Federica Ungaro, Daniele Noviello, Sara Lovisa, Laurent Peyrin-Biroulet, Silvio Danese
  Nature Reviews Gastroenterology & Hepatology.2022; 19(3): 169.     CrossRef
• Medical treatment of intestinal Crohn's disease
  Eula Plana Tetangco, Adam C. Stein
  Seminars in Colon and Rectal Surgery.2022; 33(1): 100862.     CrossRef
• Choosing the right biologic for complications of inflammatory bowel disease
  Shana Rakowsky, Konstantinos Papamichael, Adam S. Cheifetz
  Expert Review of Gastroenterology & Hepatology.2022; 16(3): 235.     CrossRef
• The Possible Pathogenic Role of IgG4-Producing Plasmablasts in Stricturing Crohn’s Disease
  Omar Bushara, David Joseph Escobar, Samuel Edward Weinberg, Leyu Sun, Jie Liao, Guang-Yu Yang
  Pathobiology.2022; 89(4): 187.     CrossRef
• Safety and efficacy of non-fluoroscopic endoscopic dilatation of gastrointestinal tuberculosis related strictures
  Pankaj Kumar, Anuraag Jena, Chhagan Lal Birda, Harjeet Singh, Pankaj Gupta, Kaushal Kishor Prasad, Usha Dutta, Vishal Sharma
  BMC Gastroenterology.2022;[Epub]     CrossRef
• Endoscopic balloon dilations for strictures of rectum, ileocecal valve and duodenum in a patient with X-linked inhibitor of apoptosis deficiency: a case report
  Shinsuke Otagiri, Takehiko Katsurada, Kensuke Sakurai, Junichi Sugita, Naoya Sakamoto
  Intestinal Research.2022; 20(2): 274.     CrossRef
• State-of-the-art surgery for Crohn’s disease: Part II—colonic Crohn’s disease and associated neoplasms
  Anne Macleod, Sandra L. Kavalukas, Katharina M. Scheurlen, Susan Galandiuk
  Langenbeck's Archives of Surgery.2022; 407(7): 2595.     CrossRef
• The role of interleukin-33 in organ fibrosis
  Samuele Di Carmine, Molly M Scott, Mairi H McLean, Henry J McSorley
  Discovery Immunology.2022;[Epub]     CrossRef
• Late onset crohns ileitis—A diagnostic dilemma
  Ashok Sunder, Manish Kumar, Sudip Saha, Bhagyalakshmi Satyanarayan
  Journal of Family Medicine and Primary Care.2022; 11(12): 7968.     CrossRef
• Inhibition of APE1/Ref-1 Redox Signaling Alleviates Intestinal Dysfunction and Damage to Myenteric Neurons in a Mouse Model of Spontaneous Chronic Colitis
  Lauren Sahakian, Rhiannon T Filippone, Rhian Stavely, Ainsley M Robinson, Xu Sean Yan, Raquel Abalo, Rajaraman Eri, Joel C Bornstein, Mark R Kelley, Kulmira Nurgali
  Inflammatory Bowel Diseases.2021; 27(3): 388.     CrossRef
• A postdischarge venous thromboembolism risk calculator for inflammatory bowel disease surgery
  Cary Jo R. Schlick, Tarik K. Yuce, Anthony D. Yang, Michael F. McGee, David J. Bentrem, Karl Y. Bilimoria, Ryan P. Merkow
  Surgery.2021; 169(2): 240.     CrossRef
• Presence of Obstructive Symptoms and Absence of Perianal Crohn Disease Is Predictive of Surgery After Endoscopic Balloon Dilation
  Barathi Sivasailam, Scott Manski, Alicia Wentz, Raymond K Cross
  Inflammatory Bowel Diseases.2021; 27(8): 1230.     CrossRef
• Association of Baseline Luminal Narrowing With Ileal Microbial Shifts and Gene Expression Programs and Subsequent Transmural Healing in Pediatric Crohn Disease
  Allison D Ta, Nicholas J Ollberding, Rebekah Karns, Yael Haberman, Adina L Alazraki, David Hercules, Robert Baldassano, James Markowitz, Melvin B Heyman, Sandra Kim, Barbara Kirschner, Jason M Shapiro, Joshua Noe, Maria Oliva-Hemker, Anthony Otley, Marian
  Inflammatory Bowel Diseases.2021; 27(11): 1707.     CrossRef
• Infliximab therapy intensification based on endoscopic activity is related to suppress treatment discontinuation in patients with Crohn disease
  Yuga Komaki, Shuji Kanmura, Kazuki Yutsudo, Kosuke Kuwazuru, Fukiko Komaki, Akihito Tanaka, Nobuaki Nishimata, Yoichi Sameshima, Fumisato Sasaki, Hidehisa Ohi, Yuichi Nakamura, Koichi Tokushige, Yukinori Sameshima, Akio Ido
  Medicine.2021; 100(6): e24731.     CrossRef
• Duodenal Obstruction in a Patient Previously Treated With EndoVascular Aneurysm Sealing System Repair
  Carlo Biddau, Carlo Nagliati, Michele Graziano, Lorenzo Cereser, Giovanni Terrosu, Alessandro Balani
  Vascular and Endovascular Surgery.2021; 55(8): 859.     CrossRef
• Crohn's Disease Obstructions
  Molly M. Ford
  Clinics in Colon and Rectal Surgery.2021; 34(04): 227.     CrossRef
• Transplantation of fecal microbiota from patients with inflammatory bowel disease and depression alters immune response and behavior in recipient mice
  Hyo-Min Jang, Jeon-Kyung Kim, Min-Kyung Joo, Yoon-Jung Shin, Chang Kyun Lee, Hyo-Jong Kim, Dong-Hyun Kim
  Scientific Reports.2021;[Epub]     CrossRef
• Crohn’s disease at radiological imaging: focus on techniques and intestinal tract
  Giuseppe Cicero, Silvio Mazziotti
  Intestinal Research.2021; 19(4): 365.     CrossRef
• Current Topics of the Mechanism of Intestinal Fibrosis in Crohn’s Disease
  Yusuke Honzawa, Shuji Yamamoto, Makoto Okabe, Hiroshi Seno, Hiroshi Nakase
  Immuno.2021; 1(4): 574.     CrossRef
• Worse outcomes and higher costs of care in fibrostenotic Crohn’s disease: a real-world propensity-matched analysis in the USA
  Melody Dehghan, Gabriel Wong, Edward Neuberger, Cindy Kin, Florian Rieder, K T Park
  BMJ Open Gastroenterology.2021; 8(1): e000781.     CrossRef
• Epidemiology of fibrostenosing inflammatory bowel disease
  Joyce Wing Yan Mak, Siew Chien Ng
  Journal of Digestive Diseases.2020; 21(6): 332.     CrossRef
• The Efficacy of Anti-Tumor Necrosis Factor Alpha for Symptomatic Stricturing Small Bowel Crohn’s Disease
  Mansour Alourfi, Mahmoud Mosli, Omar I Saadah
  Cureus.2020;[Epub]     CrossRef
• Roles of protein ubiquitination in inflammatory bowel disease
  Yue Xiao, Qi Huang, Zherui Wu, Weilin Chen
  Immunobiology.2020; 225(6): 152026.     CrossRef
• Chirurgie des maladies inflammatoires chroniques de l’intestin
  M. Aubert, D. Mege, L. Maggiori, Y. Panis
  EMC - Gastro-entérologie.2020; 37(3): 1.     CrossRef
• Development, validation, and application of a novel tool to measure disease-related knowledge in patients with inflammatory bowel disease
  Hyuk Yoon, Suk-Kyun Yang, Hoonsub So, Ko Eun Lee, Sang Hyoung Park, Sung-Ae Jung, Joong Haeng Choh, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee
  The Korean Journal of Internal Medicine.2019; 34(1): 81.     CrossRef
• Unusual causes of large bowel obstruction
  Nicholas G. Farkas, Ted Joseph P. Welman, Talisa Ross, Sarah Brown, Jason J. Smith, Nikhil Pawa
  Current Problems in Surgery.2019; 56(2): 49.     CrossRef
• TTC7A: Steward of Intestinal Health
  Sasha Jardine, Neel Dhingani, Aleixo M. Muise
  Cellular and Molecular Gastroenterology and Hepatology.2019; 7(3): 555.     CrossRef
• Segmental dilatation following side‐to‐side isoperistaltic strictureplasty in Crohn’s disease: a note of caution
  Brendan Desmond, Ashok Gunawardene, Ben Griffiths, John Keating
  ANZ Journal of Surgery.2019;[Epub]     CrossRef
• Small bowel strictures
  Deniz Durmush, Arthur J. Kaffes
  Current Opinion in Gastroenterology.2019; 35(3): 235.     CrossRef
• Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn’s Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort Study
  Roy Frei, Nicolas Fournier, Jonas Zeitz, Michael Scharl, Bernhard Morell, Thomas Greuter, Philipp Schreiner, Benjamin Misselwitz, Ekaterina Safroneeva, Alain M Schoepfer, Stephan R Vavricka, Gerhard Rogler, Luc Biedermann
  Journal of Crohn's and Colitis.2019; 13(10): 1292.     CrossRef
• Clinical Features and Prognosis of Crohn’s Disease with Upper Gastrointestinal Tract Phenotype in Chinese Patients
  Xiao-Wei Sun, Juan Wei, Zhao Yang, Xin-Xin Jin, Hai-Jun Wan, Bo-Si Yuan, Miao-Fang Yang, Jiong Liu, Fang-Yu Wang
  Digestive Diseases and Sciences.2019; 64(11): 3291.     CrossRef
• Phosphatidylinositol 3-kinase p110δ drives intestinal fibrosis in SHIP deficiency
  Young Lo, Jean Philippe Sauve, Susan C. Menzies, Theodore S. Steiner, Laura M. Sly
  Mucosal Immunology.2019; 12(5): 1187.     CrossRef
• Occult Adenocarcinoma Arising in Crohn’s-Related Strictures: A Case Series
  Kevin Singh, Amandeep Singh, Jessica Philpott, David Liska, Keith Lai
  Crohn's & Colitis 360.2019;[Epub]     CrossRef
• Agentes anti-factor de necrosis tumoral en enfermedad de Crohn y colitis ulcerosa: más allá de la enfermedad luminal
  Laura Núñez-Gómez, Francisco Mesonero-Gismero, Agustín Albillos-Martínez, Antonio López-Sanromán
  Gastroenterología y Hepatología.2018; 41(9): 576.     CrossRef
• Parathyroid Hormone–Like Hormone Induces Epithelial-to-Mesenchymal Transition of Intestinal Epithelial Cells by Activating the Runt-Related Transcription Factor 2
  Shuying He, Minmin Xue, Cuiping Liu, Fang Xie, Lan Bai
  The American Journal of Pathology.2018; 188(6): 1374.     CrossRef
• Anti-tumour necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal disease
  Laura Núñez-Gómez, Francisco Mesonero-Gismero, Agustín Albillos-Martínez, Antonio López-Sanromán
  Gastroenterología y Hepatología (English Edition).2018; 41(9): 576.     CrossRef
• Long-Term Outcomes of Endoscopic Balloon Dilation for Benign Strictures in Patients with Inflammatory Bowel Disease
  Hye Won Lee, Soo Jung Park, Seong Ran Jeon, Byong Duk Ye, Jae Jun Park, Jae Hee Cheon, Tae Il Kim, Won Ho Kim
  Gut and Liver.2018; 12(5): 530.     CrossRef
• Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study
  Jaeyoung Chun, Jong Pil Im, Ji Won Kim, Kook Lae Lee, Chang Hwan Choi, Hyunsoo Kim, Jae Hee Cheon, Byong Duk Ye, Young-Ho Kim, You Sun Kim, Yoon Tae Jeen, Dong Soo Han, Won Ho Kim, Joo Sung Kim
  Gut and Liver.2018; 12(5): 544.     CrossRef
• Computed tomography and magnetic resonance imaging in the diagnosis of the small and large intestine strictures in Crohn’s disease. Radiological semiotics and assessment of the inflammation activity
  S. E. Dubrova, G. A. Stashuk, N. V. Nikitina, Yu. K. Bogomazov
  Almanac of Clinical Medicine.2018; 46(7): 725.     CrossRef
• A distinct epigenetic profile distinguishes stenotic from non-inflamed fibroblasts in the ileal mucosa of Crohn’s disease patients
  Andrew Y. F. Li Yim, Jessica R. de Bruyn, Nicolette W. Duijvis, Catriona Sharp, Enrico Ferrero, Wouter J. de Jonge, Manon E. Wildenberg, Marcel M. A. M. Mannens, Christianne J. Buskens, Geert R. D’Haens, Peter Henneman, Anje A. te Velde, Osman El-Maarri
  PLOS ONE.2018; 13(12): e0209656.     CrossRef
• Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
  Shu-Chen Wei, Ting-An Chang, Te-Hsin Chao, Jinn-Shiun Chen, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tien-Yu Huang, Tzu-Chi Hsu, Chun-Chi Lin, Hung-Hsin Lin, Jen-Kou Lin, Wei-Chen Lin, Yen-Hsuan Ni, Ming-Jium Shieh, I-Lun Shih, Chi
  Intestinal Research.2017; 15(3): 285.     CrossRef
• Biodegradable Stents
  Deepanshu Jain, Ejaz Mahmood, Shashideep Singhal
  Journal of Clinical Gastroenterology.2017; 51(4): 295.     CrossRef
• Quality Indicators for Small Bowel Capsule Endoscopy
  Ki-Nam Shim, Seong Ran Jeon, Hyun Joo Jang, Jinsu Kim, Yun Jeong Lim, Kyeong Ok Kim, Hyun Joo Song, Hyun Seok Lee, Jae Jun Park, Ji Hyun Kim, Jaeyoung Chun, Soo Jung Park, Dong-Hoon Yang, Yang Won Min, Bora Keum, Bo-In Lee
  Clinical Endoscopy.2017; 50(2): 148.     CrossRef
• Editorial: Factors Promoting Development of Fibrosis in Crohn’s Disease
  Jennifer Bailey
  Frontiers in Medicine.2017;[Epub]     CrossRef
• Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn’s disease, and clinical prognosis in inflammatory bowel disease
  Diana Hoang-Ngoc Tran, Jiani Wang, Christina Ha, Wendy Ho, S. Anjani Mattai, Angelos Oikonomopoulos, Guy Weiss, Precious Lacey, Michelle Cheng, Christine Shieh, Caroline C. Mussatto, Samantha Ho, Daniel Hommes, Hon Wai Koon
  BMC Gastroenterology.2017;[Epub]     CrossRef
• Advanced Oxidation Protein Products Induce Epithelial–Mesenchymal Transition of Intestinal Epithelial Cellsviaa PKC δ-Mediated, Redox-Dependent Signaling Pathway
  Xiaoping Xu, Shibo Sun, Fang Xie, Juanjuan Ma, Jing Tang, Shuying He, Lan Bai
  Antioxidants & Redox Signaling.2017; 27(1): 37.     CrossRef
• Incidence of and Risk Factors for Free Bowel Perforation in Patients with Crohn’s Disease
  Jong Wook Kim, Ho-Su Lee, Byong Duk Ye, Suk-Kyun Yang, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Yong Sik Yoon, Chang Sik Yu, Jin-Ho Kim
  Digestive Diseases and Sciences.2017; 62(6): 1607.     CrossRef
• Crohn’s disease presenting as gastric outlet obstruction: a therapeutic challenge?
  Faisal Inayat, Waqas Ullah, Qulsoom Hussain, Khurram Shafique
  BMJ Case Reports.2017; 2017: bcr-2016-218181.     CrossRef
• Genetic Influences on the Development of Fibrosis in Crohn’s Disease
  Bram Verstockt, Isabelle Cleynen
  Frontiers in Medicine.2016;[Epub]     CrossRef
• Crohn's Disease: Specific Concerns in the Elderly
  Wei-Chen Lin, Ming-Jen Chen, Cheng-Hsin Chu, Tsang-En Wang, Horng-Yuan Wang, Shou-Chuan Shih, Chen-Wang Chang
  International Journal of Gerontology.2016; 10(3): 126.     CrossRef
• Structural and molecular features of intestinal strictures in rats with Crohn's-like disease
  Petra Talapka
  World Journal of Gastroenterology.2016; 22(22): 5154.     CrossRef
• Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn’s Disease: Results from the CONNECT Study
  Jee Hye Kwon, Jong Pil Im, Byong Duk Ye, Jae Hee Cheon, Hyun Joo Jang, Kang Moon Lee, You Sun Kim, Sang Wook Kim, Young Ho Kim, Geun Am Song, Dong Soo Han, Won Ho Kim, Joo Sung Kim
  Gut and Liver.2016; 10(4): 595.     CrossRef
• Small Bowel Stricture Mimicking Megacolon in a Patient with Crohn's Disease
  Samuel Raimundo Fernandes, Luís Araújo Correia, José Velosa
  GE Portuguese Journal of Gastroenterology.2016; 23(6): 319.     CrossRef
• Factors Associated with Anxiety and Depression in Korean Patients with Inactive Inflammatory Bowel Disease
  Min Chul Kim, Yoon Suk Jung, Young Seok Song, Jung In Lee, Jung Ho Park, Chong Il Sohn, Kyu Yong Choi, Dong Il Park
  Gut and Liver.2016;[Epub]     CrossRef
• Disease monitoring in inflammatory bowel disease
  Shannon Chang
  World Journal of Gastroenterology.2015; 21(40): 11246.     CrossRef
• Endoskopie in Diagnose, Therapie und Nachsorge
  H. Neumann, M. F. Neurath, Raja Atreya
  MMW - Fortschritte der Medizin.2015; 157(12): 63.     CrossRef
• Endoscopic Therapy in Inflammatory Bowel Diseases
  Helmut Neumann, Markus F. Neurath, Raja Atreya
  Visceral Medicine.2015; 31(4): 280.     CrossRef